Market Overview:
The global dexchlorpheniramine market is expected to grow at a CAGR of 3.5% from 2018 to 2030. The patent segment is expected to dominate the market in terms of revenue share during the forecast period. The antiallergic agent application segment is projected to be the fastest-growing application segment during the forecast period. North America dominates the global dexchlorpheniramine market, followed by Europe and Asia Pacific.
Product Definition:
Dexchlorpheniramine is an antihistamine medication used to treat symptoms of allergies, such as sneezing, watery eyes, and a runny nose. It may also be used to treat other conditions as determined by your doctor. Dexchlorpheniramine is important because it helps relieve the symptoms of allergic reactions.
Patent:
Patent is a legal right granted by the government to an individual or a company for inventions, discoveries or original ideas. The patent system is designed in such a way that it protects the rights of the inventors and gives them full control over their discoveries until 20 years after their death. In order to obtain patent, an application has to be filed with the concerned authority wherein detailed description of invention is given along with samples or prototypes of same.
Generic:
Dexchlorpheniramine (DCPA) is an antihistamine used to treat allergies and cold symptoms. It works by blocking the action of histamine, a chemical that causes itching, swelling, and watery eyes as well as other body fluids.S.
Application Insights:
The antiallergic agent segment dominated the global market in terms of revenue share in 2017. The product is used for the treatment of allergic rhinitis and other allergic conditions of the skin such as asthma, eczema, and hives. Allergy symptoms include runny nose with redness and itching around eyes & mouth due to increased blood flow to nasal area due to histamine release from mast cells.
The H1-receptor antagonist segment is expected to witness lucrative growth over the forecast period owing to its use as an active pharmaceutical ingredient (API) in several drugs prescribed for colds or allergy symptoms. The presence of a strong pipeline supporting this application coupled with growing awareness regarding cold medicines will drive demand over forecasted period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing prevalence of allergic conditions and related symptoms, such as runny nose, rhinitis, and itchy skin among others. In addition, growing number of product launches in this region is also expected to contribute towards growth. For instance, in September 2016 Merck & Co., Inc.; announced about the launch of Benadryl Allergy Relief Tablets containing dexchlorpheniramine maleate (dexchlorphenamine) for itch relief. These tablets are formulated without sorbitol and are gluten-free; thus making them suitable for people with celiac disease or gluten intolerance/ sensitivity.
Growth Factors:
- Increasing prevalence of allergic rhinitis and asthma
- Rising awareness about the benefits of dexchlorpheniramine over other antihistamines
- Growing demand for over-the-counter drugs for the treatment of allergies and colds
- Availability of generic dexchlorpheniramine formulations at a lower cost
- Technological advancements in the manufacturing process
Scope Of The Report
Report Attributes
Report Details
Report Title
Dexchlorpheniramine Market Research Report
By Type
Patent, Generic
By Application
Antiallergic Agent, Histamine H₁-Receptor Antagonist
By Companies
LETI, Novartis, Hypera Pharma, Woodward, Merck, Johnson and Johnson, Ethical Pharma, Gems Pharma, KPL Pharma, GlaxoSmithKline, Ying Yuan, Schering-Plough, Towa Yakuhin, Mantecorp FSA, Kalbe, Teva, Bayer, Mekophar, CFR Pharmaceuticals, Armoxindo Farma, Sawai Seiyaku, Pfizer, Instituto Sanitas, Caillon and Hamonet, Kobayashi Kako, Greater Pharma, Teuto Brasileiro, Harsen Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Dexchlorpheniramine Market Report Segments:
The global Dexchlorpheniramine market is segmented on the basis of:
Types
Patent, Generic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antiallergic Agent, Histamine H₁-Receptor Antagonist
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LETI
- Novartis
- Hypera Pharma
- Woodward
- Merck
- Johnson and Johnson
- Ethical Pharma
- Gems Pharma
- KPL Pharma
- GlaxoSmithKline
- Ying Yuan
- Schering-Plough
- Towa Yakuhin
- Mantecorp FSA
- Kalbe
- Teva
- Bayer
- Mekophar
- CFR Pharmaceuticals
- Armoxindo Farma
- Sawai Seiyaku
- Pfizer
- Instituto Sanitas
- Caillon and Hamonet
- Kobayashi Kako
- Greater Pharma
- Teuto Brasileiro
- Harsen Laboratories
Highlights of The Dexchlorpheniramine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Patent
- Generic
- By Application:
- Antiallergic Agent
- Histamine H₁-Receptor Antagonist
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dexchlorpheniramine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dexchlorpheniramine is a medication used to treat allergies. It works by blocking the action of histamines in the body.
Some of the major players in the dexchlorpheniramine market are LETI, Novartis, Hypera Pharma, Woodward, Merck, Johnson and Johnson, Ethical Pharma, Gems Pharma, KPL Pharma, GlaxoSmithKline, Ying Yuan, Schering-Plough, Towa Yakuhin, Mantecorp FSA, Kalbe, Teva, Bayer, Mekophar, CFR Pharmaceuticals, Armoxindo Farma, Sawai Seiyaku, Pfizer, Instituto Sanitas, Caillon and Hamonet, Kobayashi Kako, Greater Pharma, Teuto Brasileiro, Harsen Laboratories.
The dexchlorpheniramine market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dexchlorpheniramine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dexchlorpheniramine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dexchlorpheniramine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dexchlorpheniramine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dexchlorpheniramine Market Size & Forecast, 2018-2028
4.5.1 Dexchlorpheniramine Market Size and Y-o-Y Growth
4.5.2 Dexchlorpheniramine Market Absolute $ Opportunity
Chapter 5 Global Dexchlorpheniramine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dexchlorpheniramine Market Size Forecast by Type
5.2.1 Patent
5.2.2 Generic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dexchlorpheniramine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dexchlorpheniramine Market Size Forecast by Applications
6.2.1 Antiallergic Agent
6.2.2 Histamine H₁-Receptor Antagonist
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dexchlorpheniramine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dexchlorpheniramine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dexchlorpheniramine Analysis and Forecast
9.1 Introduction
9.2 North America Dexchlorpheniramine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dexchlorpheniramine Market Size Forecast by Type
9.6.1 Patent
9.6.2 Generic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dexchlorpheniramine Market Size Forecast by Applications
9.10.1 Antiallergic Agent
9.10.2 Histamine H₁-Receptor Antagonist
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dexchlorpheniramine Analysis and Forecast
10.1 Introduction
10.2 Europe Dexchlorpheniramine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dexchlorpheniramine Market Size Forecast by Type
10.6.1 Patent
10.6.2 Generic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dexchlorpheniramine Market Size Forecast by Applications
10.10.1 Antiallergic Agent
10.10.2 Histamine H₁-Receptor Antagonist
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dexchlorpheniramine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dexchlorpheniramine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dexchlorpheniramine Market Size Forecast by Type
11.6.1 Patent
11.6.2 Generic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dexchlorpheniramine Market Size Forecast by Applications
11.10.1 Antiallergic Agent
11.10.2 Histamine H₁-Receptor Antagonist
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dexchlorpheniramine Analysis and Forecast
12.1 Introduction
12.2 Latin America Dexchlorpheniramine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dexchlorpheniramine Market Size Forecast by Type
12.6.1 Patent
12.6.2 Generic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dexchlorpheniramine Market Size Forecast by Applications
12.10.1 Antiallergic Agent
12.10.2 Histamine H₁-Receptor Antagonist
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dexchlorpheniramine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dexchlorpheniramine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dexchlorpheniramine Market Size Forecast by Type
13.6.1 Patent
13.6.2 Generic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dexchlorpheniramine Market Size Forecast by Applications
13.10.1 Antiallergic Agent
13.10.2 Histamine H₁-Receptor Antagonist
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dexchlorpheniramine Market: Competitive Dashboard
14.2 Global Dexchlorpheniramine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 LETI
14.3.2 Novartis
14.3.3 Hypera Pharma
14.3.4 Woodward
14.3.5 Merck
14.3.6 Johnson and Johnson
14.3.7 Ethical Pharma
14.3.8 Gems Pharma
14.3.9 KPL Pharma
14.3.10 GlaxoSmithKline
14.3.11 Ying Yuan
14.3.12 Schering-Plough
14.3.13 Towa Yakuhin
14.3.14 Mantecorp FSA
14.3.15 Kalbe
14.3.16 Teva
14.3.17 Bayer
14.3.18 Mekophar
14.3.19 CFR Pharmaceuticals
14.3.20 Armoxindo Farma
14.3.21 Sawai Seiyaku
14.3.22 Pfizer
14.3.23 Instituto Sanitas
14.3.24 Caillon and Hamonet
14.3.25 Kobayashi Kako
14.3.26 Greater Pharma
14.3.27 Teuto Brasileiro
14.3.28 Harsen Laboratories
